SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-19-062161
Filing Date
2019-12-30
Accepted
2019-12-30 17:13:30
Documents
2
Period of Report
2019-12-27

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 2135
2 POA DOCUMENT poa.txt EX-24.3_885114 3658
  Complete submission text file 0001209191-19-062161.txt   7201
Mailing Address ONE NEENAH CENTER, 4TH FLOOR P.O. BOX 669 NEENAH WI 54957
Business Address
Gulfo Adele M. (Reporting) CIK: 0001647102 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-37929 | Film No.: 191317305

Mailing Address SUITE 1, 3RD FLOOR 11-12 ST. JAMES SQUARE LONDON X0 SW1Y 4LB
Business Address SUITE 1, 3RD FLOOR 11-12 ST. JAMES SQUARE LONDON X0 SW1Y 4LB 44(0)207 400 3347
Myovant Sciences Ltd. (Issuer) CIK: 0001679082 (see all company filings)

IRS No.: 000000000 | State of Incorp.: CA | Fiscal Year End: 0331
SIC: 2834 Pharmaceutical Preparations